- Todos > Medicine Access and Rational Use > Rational Use
- Todos > Medicine Access and Rational Use > Selection
- Palabras clave > country case studies
- Palabras clave > criteria of medicines selection
- Palabras clave > essential medicines - concept
- Palabras clave > essential medicines history
- Palabras clave > Essential Medicines List (EML)
- Palabras clave > future trends - medicines
- Palabras clave > national list of essential medicines
- Palabras clave > selection process
- Palabras clave > usage of EML
- Palabras clave > WHO Model List of Essential Medicines
(2015; 50 pages)
Since the establishment of the concept of “essential medicines” by the World Health Organization (WHO), it has evolved and matured into a critically important element of national health system policies and practices. As the movement toward universal health coverage strengthens, so does the role of essential medicines as a key part of bringing to all people the health services they need without suffering financial hardship when paying for them.
As the WHO moves toward a revision of the model Essential Medicines List, it is timely to revisit the evolution of the list since 1977 and its use across a range of countries.
The purpose of this report is to:
- Summarize how the Essential Medicines List has changed between 1977 and 2013 and the process by which the model list is revised
- Describe the ways in which the WHO’s list is used by national health systems in developing their own lists of essential medicines
- Review and compare the national lists for a range of countries and factors affecting local implementation
- Provide considerations for future revisions of the WHO model list.
In reviewing national systems, a selection of middle- and low-income countries were selected from Asia, Africa and Latin America, including Brazil, China, India, Indonesia, Kenya, Malawi, the Philippines, South Africa, and Tanzania.